Ihuman Price To Operating Cash Flows Ratio from 2010 to 2024
| IH Stock | USD 1.55 0.09 5.49% |
Price To Operating Cash Flows Ratio | First Reported 2010-12-31 | Previous Quarter 7.07526236 | Current Value 7.43 | Quarterly Volatility 577.09109632 |
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 34.8 M, Depreciation And Amortization of 6 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0117 or PTB Ratio of 1.34. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
Ihuman | Price To Operating Cash Flows Ratio |
Latest Ihuman's Price To Operating Cash Flows Ratio Growth Pattern
Below is the plot of the Price To Operating Cash Flows Ratio of Ihuman Inc over the last few years. It is Ihuman's Price To Operating Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
| Price To Operating Cash Flows Ratio | 10 Years Trend |
|
Price To Operating Cash Flows Ratio |
| Timeline |
Ihuman Price To Operating Cash Flows Ratio Regression Statistics
| Arithmetic Mean | (651.04) | |
| Coefficient Of Variation | (88.64) | |
| Mean Deviation | 545.70 | |
| Median | (1,106) | |
| Standard Deviation | 577.09 | |
| Sample Variance | 333,034 | |
| Range | 1.2K | |
| R-Value | 0.84 | |
| Mean Square Error | 105,040 | |
| R-Squared | 0.71 | |
| Significance | 0.000086 | |
| Slope | 108.51 | |
| Total Sum of Squares | 4.7M |
Ihuman Price To Operating Cash Flows Ratio History
About Ihuman Financial Statements
Investors use fundamental indicators, such as Ihuman's Price To Operating Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Price To Operating Cash Flows Ratio | 7.08 | 7.43 |
Currently Active Assets on Macroaxis
Check out the analysis of Ihuman Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.16) | Revenue Per Share 18.263 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0456 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.